SBP-401

N/A

Report date: 2024/11/07 16:30:27

NME

Base Information

Drug NameSBP-401

Drug Alias NameSBP-401

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionHigh Mobility Group Protein B1 inhibitors

TargetsHigh Mobility Group Protein B1

Therapy Area/IndicationsHeart Failure

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesSpark Biopharma Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsHeart Failure

Inactive IndicationsN/A

ATC CodeN/A